By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Robert-Roessle-Str. 10

Berlin    13125  Germany
Phone: 49-30-9489-2604 Fax: 49-30-9489-2609


Company News
Glycotope Appoints Dr. Alfredo Zurlo As Chief Medical Officer 4/29/2016 7:02:14 AM
Glycotope Names Paul G Higham As New Chief Executive Officer 1/7/2016 11:06:15 AM
Biotech Glycotope Manages To Squeeze $76 Million Out Of German Billionaires 3/12/2014 8:25:42 AM
Glycotope Reported Promising First-in-Man Data at American Society of Clinical Oncology 2013 for Its Glycooptimized Anti-EGFR Antibody CetuGEX™ to Treat Solid Tumors 6/5/2013 9:14:09 AM
Glycotope Moves PankoMab™ Towards Phase-II Clinical Development 6/15/2012 9:04:11 AM
Glycotope Moves FSH-GEX™ into Phase-II Clinical Development 6/8/2012 9:35:09 AM
Glycotope Enrolls First Patients in Phase I Trial with TrasGEX(TM), a Glycooptimized HER2 Biobetter Antibody 9/19/2011 10:52:19 AM
Glycotope Enrolls First Patients in Phase I Trial for FSH-GEX(TM) 5/18/2011 11:14:44 AM
Glycotope Expands GMP Production Facility to 11 kg Antibody per Year 4/5/2011 9:01:59 AM
Glycotope Receives Innovation Award Berlin Brandenburg 2010 12/14/2010 10:42:51 AM